tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market

Intensity Therapeutics, Inc. (INTS) Income Statement

Compare
28 Followers

Intensity Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Intensity Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Intensity Therapeutics, Inc.'s net income was $-3.51M. See Intensity Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -147.00K$ -179.04K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 8.17M$ 7.55M$ 8.01M$ 6.22M$ 5.68M
Depreciation and Amortization
$ 147.00K$ 179.04K$ 236.56K$ 206.30K$ 171.86K
EBITDA
$ -10.09M$ -7.40M$ -7.88M$ -6.03M$ -5.38M
Operating Income
$ -8.32M$ -7.63M$ -8.01M$ -6.22M$ -5.68M
Other Income/Expenses
$ -2.22M$ 49.06K$ 118.12K$ 192.77K$ 295.70K
Pretax Income
$ -10.54M$ -7.58M$ -7.90M$ -6.03M$ -5.38M
Net Income
$ -10.54M$ -7.45M$ -7.89M$ -5.96M$ -5.23M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.38$ -0.57$ -0.60$ -0.45$ -0.40
Diluted EPS
$ -1.38$ -0.57$ -0.60$ -0.45$ -0.40
Weighted Average Shares Outstanding
8.62M 13.10M 13.10M 13.10M 13.10M
Weighted Average Shares Outstanding (Diluted)
8.62M 13.10M 13.10M 13.10M 13.10M
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis